Figure 3.
Scanning electron microscopy showing the alveolar bone loss of animals with diabetes and/or periodontal disease treated or not treated with β-glucan at a dose of 30 mg/kg/day for 28 days: (A) control; (B) diabetes; (C) periodontal disease; (D) β-glucan; (E) diabetes + periodontal disease; (F) diabetes + β-glucan; (G) periodontal disease + β-glucan; (H) diabetes + periodontal disease + β-glucan.